The Gross Margin of Biofermin Pharmaceutical Co Ltd (4517.T) is 58.40%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2021-03-31 | 58.40% |
| 2020-03-31 | 61.41% |
| 2019-03-31 | 60.63% |
| 2018-03-31 | 65.35% |
| 2017-03-31 | 62.03% |
| 2016-03-31 | 60.18% |
| 2015-03-31 | 62.58% |
| 2014-03-31 | 65.20% |
| 2013-03-31 | 69.89% |
| 2012-03-31 | 70.30% |